FS
Fred Schwarzer
CEO at MultiValent Biotherapeutics
United States
Overview
Fred Schwarzer is the CEO of MultiValent Biotherapeutics, with a distinguished career that includes serving as Chief Executive Officer at IGM Biosciences, Inc. and leading successful ventures at Charter Life Sciences and Heska Corporation. Schwarzer's extensive executive experience and leadership roles highlight his ability to drive growth and success within the biotechnology industry.
Work Experience
CEO
2024 - Current
Chief Executive Officer
2010 - 2024
Managing Partner
2003 - 2018
President
2001 - 2003
Chairman Of The Board
1999 - 2001
Senior Vice President
1999 - 2001
C.M. Capital is a private investment company for prominent institutions and individuals.
Chief Executive Officer
1994 - 1998